Case report: Prazosin augmentation for treating comorbid treatment-resistant depression and chronic post-traumatic stress disorder
Psychological trauma in childhood can lead to post-traumatic disorder (PTSD) with protracted comorbid depression, which responds poorly to conventional antidepressants. Previous studies have shown that prazosin, an α1-adrenergic receptor antagonist, can help eliminate nightmares and improve sleep qu...
Main Authors: | Ping Guo, Yu Fang, Ming Feng, Xudong Zhao, Shikai Wang, Mincai Qian, Juanjuan Huang, Huanxin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.803220/full |
Similar Items
-
Use of Prazosin for Pediatric Post-Traumatic Stress Disorder With Nightmares and/or Sleep Disorder: Case Series of 18 Patients Prospectively Assessed
by: Vladimir Ferrafiat, et al.
Published: (2020-07-01) -
Case series: Continued remission of PTSD symptoms after discontinuation of prazosin
by: Christie Richardson, et al.
Published: (2023-04-01) -
Evaluation of low dose prazosin for PTSD-associated nightmares in children and adolescents
by: Nancy Hudson, PharmD, et al.
Published: (2023-03-01) -
Investigation of the Atypical Glass Transition and Recrystallization Behavior of Amorphous Prazosin Salts
by: Arvind K. Bansal, et al.
Published: (2011-08-01) -
The efficacy of administration of prazosin in reducing the risk of recurrent urethral obstruction in male cats
by: Rebecca Hearne
Published: (2023-11-01)